Related references
Note: Only part of the references are listed.L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Hung-Yun Lin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Steven Fletcher et al.
BIOCHEMISTRY AND CELL BIOLOGY (2009)
Signal Transducers and Activators of Transcription Mediate Fibroblast Growth Factor-Induced Vascular Endothelial Morphogenesis
Xinhai Yang et al.
CANCER RESEARCH (2009)
Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
Dong Bai et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-α-positive and -negative breast cancer cells
Hung-Yun Lin et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Resveratrol causes COX-2-and p53-dependent apoptosis in head and neck squamous cell cancer cells
Hung-Yun Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast
Giuseppe Perrone et al.
VIRCHOWS ARCHIV (2007)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells
Heng-Yuan Tang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Integrin αVβ3 contains a receptor site for resveratrol
Hung-Yun Lin et al.
FASEB JOURNAL (2006)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Contribution of inducible nitric oxide synthase and cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast cells of human fetal membrane tissues
B Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The complexity of p53 stabilization and activation
M. F. Lavin et al.
CELL DEATH AND DIFFERENTIATION (2006)
Membrane receptors mediating thyroid hormone action
PJ Davis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh et al.
ENDOCRINOLOGY (2005)
Resveratrol: Preventing properties against vascular alterations and ageing
D Delmas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis
CA Corcoran et al.
ONCOGENE (2005)
Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer
NG Azios et al.
NEOPLASIA (2005)
Integrin β3 overexpression suppresses tumor growth in a human model of gliomagenesis:: Implications for the role of β3 overexpression in glioblastoma multiforme
M Kanamori et al.
CANCER RESEARCH (2004)
Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKCα inhibition
JR Stewart et al.
INVESTIGATIONAL NEW DRUGS (2004)
Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos
L Scapoli et al.
ONCOGENE (2004)
Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells
S Zhang et al.
BRITISH JOURNAL OF CANCER (2004)
Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells
SO Mueller et al.
TOXICOLOGICAL SCIENCES (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and-2
M Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
DNA-dependent acetylation of p53 by the transcription coactivator p300
D Dornan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Estrogen activation of cyclic adenosine 5′-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway
CNB Wade et al.
ENDOCRINOLOGY (2003)
Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells
DB Chen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Molecular mechanism of the chemopreventive effect of resveratrol
ZG Dong
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms - Role of p38-mediated pathways
HF Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
p53-mediated induction of Cox-2 counteracts p53-or genotoxic stress-induced apoptosis
JA Han et al.
EMBO JOURNAL (2002)
Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action
DI Cho et al.
LIFE SCIENCES (2002)
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol
ZG Li et al.
CARCINOGENESIS (2002)
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
HY Lin et al.
JOURNAL OF UROLOGY (2002)
Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1
G Zahner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The role of mitogen-activated protein (MAP) kinase in breast cancer
RJ Santen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells
G Serrero et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases
NA Barlev et al.
MOLECULAR CELL (2001)
Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen
JG King et al.
ONCOGENE (2001)
Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2
N Ueno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents
M Mahyar-Roemer et al.
ONCOGENE (2001)
Post-translational modifications and activation of p53 by genotoxic stresses
E Appella et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase
A Shih et al.
BIOCHEMISTRY (2001)
Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins
PJ Moos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Ligand binding to integrins
EF Plow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Extinction of Rac1 and Cdc42Hs signalling defines a novel p53-dependent apoptotic pathway
P Lassus et al.
ONCOGENE (2000)
Regulation of p53 stability and activity in response to genotoxic stress
MS Colman et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2000)
Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation
M Kapoor et al.
ONCOGENE (2000)
Share Paper
